Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Manticore Pharmaceuticals

1996 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of cobalamin bioconjugates as potential anti-cancer drugs. The company has developed a method to target the delivery of cytotoxic anticancer drugs to tumor cells by using vitamin B12 as delivery vehicle. It has developed fluorescent cobalamin conjugates useful as diagnostic imaging agents in breast cancer surgery and other diagnostic procedures.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Acquirer
Inflabloc Pharmaceuticals
Primary Office
  • 2401 South Foothill boulevard
  • Salt Lake City, UT 84109
  • United States

Manticore Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Manticore Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Manticore Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Charles Grissom Ph.D Chairman & Co-Founder
Frederick West Co-Founder

Manticore Pharmaceuticals Board Members (1)

Name Representing Role Since Contact
Info
0000000 0000000 00.0 Manticore Pharmaceuticals Chairman & Co-Founder 000 0000